Pharmaids Pharmaceuticals Ltd — Important, 12-01-2026: Company Update

Pharmaids Pharmaceuticals received a routine compliance certificate regarding its share dematerialization process for the quarter ending December 31, 2025. This confirms that all physical shares submitted for conversion into electronic format were correctly processed, cancelled, and investor records with depositories like NSDL and CDSL were updated efficiently. This update assures investors of robust and accurate management of their shareholdings.